Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway

Luteolin, a flavonoid, as an anticancer agent: A review

(2019) Muhammad Imran et al.   BIOMEDICINE & PHARMACOTHERAPY

Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer

(2019) Aya Naiki-Ito et al.   CARCINOGENESIS

GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis

(2018) Taku Naiki et al.   Oncotarget

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Absorption and Metabolism of Luteolin in Rats and Humans in Relation to in Vitro Anti-inflammatory Effects

(2018) Natsumi Hayasaka et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes

(2017) Shin-ichi Oka et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

(2017) Joaquim Bellmunt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer

(2017) Govindi J. Samaranayake et al.   Nature Communications

Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma

(2016) Emmanuel Seront et al.   BJU INTERNATIONAL

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks

(2016) Marcus G. Cumberbatch et al.   EUROPEAN UROLOGY

Metabolic Fate of Luteolin in Rats: Its Relationship to Anti-inflammatory Effect

(2016) Ayako Kure et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review

(2014) Ashok Kumar Pandurangan et al.   Asian Pacific Journal of Cancer Prevention

GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer

(2014) Taku Naiki et al.   CARCINOGENESIS

ROS Function in Redox Signaling and Oxidative Stress

(2014) Michael Schieber et al.   CURRENT BIOLOGY

Phase II study of everolimus in metastatic urothelial cancer

(2013) Matthew I. Milowsky et al.   BJU INTERNATIONAL

Modulation of oxidative stress as an anticancer strategy

(2013) Chiara Gorrini et al.   NATURE REVIEWS DRUG DISCOVERY

Expression of glutathione peroxidase 2 is associated with not only early hepatocarcinogenesis but also late stage metastasis

(2013) Shugo Suzuki et al.   TOXICOLOGY

The Impact of Squamous and Glandular Differentiation on Survival After Radical Cystectomy for Urothelial Carcinoma

(2012) Simon P. Kim et al.   JOURNAL OF UROLOGY

A Novel Local Recycling Mechanism That Enhances Enteric Bioavailability of Flavonoids and Prolongs Their Residence Time in the Gut

(2012) Bijun Xia et al.   MOLECULAR PHARMACEUTICS

Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System

(2012) Kendall S. Frazier et al.   TOXICOLOGIC PATHOLOGY

Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells

(2011) E. Chiong et al.   CLINICAL CANCER RESEARCH

Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway

(2011) Sei Yoshida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression status and prognostic significance of mammalian target of rapamycin pathway members in urothelial carcinoma of urinary bladder after cystectomy

(2010) Luciana Schultz et al.   CANCER

CDK Inhibitors: Cell Cycle Regulators and Beyond

(2008) Arnaud Besson et al.   DEVELOPMENTAL CELL

Oxidative stress in environmental-induced carcinogenesis

(2008) Salvador Mena et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer

(2007) Terumasa Noike et al.   HUMAN PATHOLOGY

Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-butyl-N-(4-hydroxybutyl) nitrosamine

(2003) S. Osawa et al.   BJU INTERNATIONAL